| Karina Mariel Garcia Collazo, MD | |
|
Est. Valle Verde #41, Calle Quebrada, Manati, PR 00674 | |
| (787) 884-7668 | |
| Not Available |
| Full Name | Karina Mariel Garcia Collazo |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | Est. Valle Verde #41, Manati, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043826142 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 21982 (Puerto Rico) | Primary |
| Entity Name | Cdt Dr. Melendez Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972818318 PECOS PAC ID: 4284892498 Enrollment ID: O20120220000528 |
News Archive
Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
It appears that a drug commonly used to treat alcohol and drug addiction has a similar effect on the compulsive behavior of kleptomaniacs – it curbs their urge to steal, according to new research at the University of Minnesota.
› Verified 7 days ago
| Entity Name | Salud Integral En La Montana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639372618 PECOS PAC ID: 8527972827 Enrollment ID: O20160122000568 |
News Archive
Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
It appears that a drug commonly used to treat alcohol and drug addiction has a similar effect on the compulsive behavior of kleptomaniacs – it curbs their urge to steal, according to new research at the University of Minnesota.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karina Mariel Garcia Collazo, MD Po Box 1334, Manati, PR 00674-1334 Ph: () - | Karina Mariel Garcia Collazo, MD Est. Valle Verde #41, Calle Quebrada, Manati, PR 00674 Ph: (787) 884-7668 |
News Archive
Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
It appears that a drug commonly used to treat alcohol and drug addiction has a similar effect on the compulsive behavior of kleptomaniacs – it curbs their urge to steal, according to new research at the University of Minnesota.
› Verified 7 days ago
Grisselle Enid Ortiz Rivera, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr #2 Reparto Curiel Park Hill Apt 1, Manati, PR 00674 Phone: 787-477-9330 | |
Synthia Marie Placencia, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Calle Hernandez Carrion Urb. Atenas, Manati, PR 00674 Phone: 787-621-3700 | |
Pedro Alberto Albelo Rivera, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Calle Hernandez Carrion, Manati, PR 00674 Phone: 621-370-0787 | |
Dr. Agnes Ileana Cardona, General Practice Medicare: Not Enrolled in Medicare Practice Location: Cfse Urb. Cordova Davila Carr. #2 Interior, Manati, PR 00674 Phone: 787-854-2495 Fax: 787-884-4009 | |
Dr. Francisco Javier Tarrats Gonzalez, MD General Practice Medicare: Medicare Enrolled Practice Location: Carr 2 Int 668 Urb Atenas, Manati Medical Center, Manati, PR 00674 Phone: 787-621-3700 | |
Dr. Roy Enrique Villafane, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Calle Hernandez Carrion, Manati, PR 00674 Phone: 787-621-3700 |